DEA CANNABIS RESCHEDULING

PUBLIC COMMENT VIEWER

Here is a random public comment on the rescheduling of cannabis to Schedule III from an anonymous commenter.

Reclassifying cannabis to Schedule 3 would facilitate comprehensive research into its therapeutic benefits and societal impacts. Evidence supports cannabinoids' efficacy in alleviating symptoms of glaucoma, Tourette syndrome, and chronic neuropathic pain, providing new avenues for treatment innovation. Societally, this reclassification could mitigate the economic burden of drug enforcement and incarceration, redirecting resources towards public health initiatives and rehabilitation programs. Socially, regulated access could promote consumer safety and responsible use practices, reducing misuse and supporting education efforts. States with medical cannabis laws report reduced opioid-related fatalities and improved quality of life for patients, highlighting cannabis's potential to combat the opioid crisis and promote inclusive healthcare solutions.

Over 42,000 public comments were submitted. Public commenters, thank you for your courage!